At the 4th Annual mHealth World Congress, Bakul Patel, an FDA policy director, tells attendees that people "have to understand the risks and the intentions." Privacy and security topics also took center stage at the conference.
The questions and comments are pouring in over the U.S. Food and Drug Administration's draft guidance on mobile medical apps, making it obvious that the government's first attempt to clarify its regulatory authority over this fast-growing field won’t be the last.